513 related articles for article (PubMed ID: 15719377)
1. Follicular thyroid lesions, elements that affect both diagnosis and prognosis.
Zeiger MA; Dackiw AP
J Surg Oncol; 2005 Mar; 89(3):108-13. PubMed ID: 15719377
[TBL] [Abstract][Full Text] [Related]
2. [Problems in the diagnosis of thyroid papillary and follicular carcinoma].
Xue WC; Hui YZ
Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):220-3. PubMed ID: 17706110
[No Abstract] [Full Text] [Related]
3. Preoperative diagnosis of the follicular variant of papillary carcinoma of the thyroid: discrepancy between image and cytologic diagnoses.
Komatsu M; Hanamura N; Tsuchiya S; Seki T; Kuroda T
Radiat Med; 1994; 12(6):293-9. PubMed ID: 7724824
[TBL] [Abstract][Full Text] [Related]
4. The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer.
Weber KB; Shroyer KR; Heinz DE; Nawaz S; Said MS; Haugen BR
Am J Clin Pathol; 2004 Oct; 122(4):524-31. PubMed ID: 15487449
[TBL] [Abstract][Full Text] [Related]
5. [Desperate search for a magic marker in difficult encapsulated follicular thyroid tumors].
Franc B
Ann Pathol; 2003 Feb; 23(1):7-10. PubMed ID: 12743495
[No Abstract] [Full Text] [Related]
6. Comment on: synchronous occurrence of anaplastic, follicular, and papillary carcinoma with follicular adenoma in thyroid gland.
Wasim NA; Hati GC; Guha D; Bhattacharya S
Indian J Pathol Microbiol; 2011; 54(2):434-5. PubMed ID: 21623130
[No Abstract] [Full Text] [Related]
7. Synchronous occurrence of anaplastic, follicular and papillary carcinomas with follicular adenoma in thyroid gland.
Bhargav PR; Gayathri KB
Indian J Pathol Microbiol; 2011; 54(2):414-5; author reply 415. PubMed ID: 21623114
[No Abstract] [Full Text] [Related]
8. Immunostaining of galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma.
Maruta J; Hashimoto H; Yamashita H; Yamashita H; Noguchi S
Diagn Cytopathol; 2004 Dec; 31(6):392-6. PubMed ID: 15540177
[TBL] [Abstract][Full Text] [Related]
9. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
10. Follicular neoplasm of the thyroid--vanishing cytologic diagnosis?
Kapur U; Wojcik EM
Diagn Cytopathol; 2007 Aug; 35(8):525-8. PubMed ID: 17636488
[TBL] [Abstract][Full Text] [Related]
11. The relation between pure papillary and follicular variant in papillary thyroid carcinoma.
Yuksel O; Kurukahvecioglu O; Ege B; Ekinci O; Aydin A; Poyraz A; Tezel E; Taneri F
Endocr Regul; 2008 Mar; 42(1):29-33. PubMed ID: 18333702
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
[TBL] [Abstract][Full Text] [Related]
14. The demise of follicular carcinoma of the thyroid gland.
LiVolsi VA; Asa SL
Thyroid; 1994; 4(2):233-6. PubMed ID: 7920009
[TBL] [Abstract][Full Text] [Related]
15. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma.
Elsheikh TM; Asa SL; Chan JK; DeLellis RA; Heffess CS; LiVolsi VA; Wenig BM
Am J Clin Pathol; 2008 Nov; 130(5):736-44. PubMed ID: 18854266
[TBL] [Abstract][Full Text] [Related]
16. [Differential diagnostic capacities of computer-aided analysis of thyroid follicular tumor images].
Poloz TL; Shkurupiĭ VA; Poloz VV
Klin Lab Diagn; 2006 Mar; (3):42-4. PubMed ID: 16749490
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid.
Rossi ED; Raffaelli M; Mule' A; Miraglia A; Lombardi CP; Vecchio FM; Fadda G
Histopathology; 2006 Jun; 48(7):795-800. PubMed ID: 16722927
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 expression in follicular tumours: an immunohistochemical study of its use as a marker of follicular carcinoma.
Ito Y; Yoshida H; Tomoda C; Miya A; Kobayashi K; Matsuzuka F; Yasuoka H; Kakudo K; Inohara H; Kuma K; Miyauchi A
Pathology; 2005 Aug; 37(4):296-8. PubMed ID: 16194828
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
20. Follicular lesions of the thyroid.
Mathur A; Olson MT; Zeiger MA
Surg Clin North Am; 2014 Jun; 94(3):499-513. PubMed ID: 24857573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
